[Treatment of heart rhythm disorders with verapamil].
The results from the administration of verapamyl (isoptine--Knoll GFR) to 30 patients with disturbed heart rhythm are presented, that are grouped as follows: supraventricular paroxysmal tachycardia (SPI)--10; auricular fibrillation (AFi)--8; auricular flutter (AFl)--7; supraventricular extrasystoles (SE)--4, and ventricular extrasystoles (VE)--1. Generally, very good results were obtained, the best effect established with SPT and AFi--rhythm restored in 70 per cent, 50 per cent respectively. Improvement was not attained in a total of 26,7 per cent, adverse effects--hypotony and AV-block were established in 6,66%.
D000293:Adolescent; D000328:Adult; D000368:Aged; D001145:Arrhythmias, Cardiac / Q000188:drug therapy*; D001794:Blood Pressure / Q000187:drug effects; D004341:Drug Evaluation; D006339:Heart Rate / Q000187:drug effects; D006801:Humans; D007275:Injections, Intravenous; D008875:Middle Aged; D011674:Pulse / Q000187:drug effects; D013607:Tablets; D014700:Verapamil / Q000627:therapeutic use*
D013607:Tablets; D014700:Verapamil
Lechenie na niakoi narusheniia na sŭrdechniia ritŭm s verapamil.